|
CD2AP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.279400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.866800E-01 |
| Normal-vs-Stage2 |
1.130620E-01 |
| Normal-vs-Stage3 |
2.476600E-01 |
| Normal-vs-Stage4 |
1.441360E-01 |
| Stage1-vs-Stage2 |
2.445000E-01 |
| Stage1-vs-Stage3 |
4.387600E-01 |
| Stage1-vs-Stage4 |
3.166000E-01 |
| Stage2-vs-Stage3 |
5.751400E-01 |
| Stage2-vs-Stage4 |
8.667400E-01 |
| Stage3-vs-Stage4 |
6.959200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.338000E-01 |
| Normal-vs-AfricanAmerican |
9.182000E-01 |
| Normal-vs-Asian |
5.088800E-01 |
| Caucasian-vs-AfricanAmerican |
4.967800E-01 |
| Caucasian-vs-Asian |
9.695000E-01 |
| AfricanAmerican-vs-Asian |
5.608400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.134200E-01 |
| Normal-vs-Female |
3.349000E-01 |
| Male-vs-Female |
4.986800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.716000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.192040E-01 |
| Normal-vs-Age(61-80Yrs) |
9.890100E-02 |
| Normal-vs-Age(81-100Yrs) |
7.482000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.728000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.366000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.158400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.939000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.848000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.096200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.113800E-01 |
| Classical-VS-Follicular |
4.05989999999745E-05 |
| Classical-VS-Other |
4.447600E-01 |
| Classical-VS-Normal |
9.826200E-01 |
| Tall-VS-Follicular |
3.701600E-03 |
| Tall-VS-Other |
3.605000E-01 |
| Tall-VS-Normal |
7.433200E-01 |
| Follicular-VS-Other |
5.261800E-01 |
| Follicular-VS-Normal |
1.662310E-03 |
| Other-VS-Normal |
3.931800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.409900E-02 |
| Normal-vs-N1 |
1.363210E-01 |
| N0-vs-N1 |
9.106400E-01 |
|
|
